Clin2
NCT07418034Possibly a fitNot yet recruiting

Lower radiation doses for HPV-related throat cancer

Head and Neck CancerHead and Neck Squamous Cell CancerHead and Neck Squamous Cell CarcinomaOropharyngeal CarcinomaOropharyngeal Squamous Cell Carcinoma (OPSCC)Oropharyngeal Human Papillomavirus-Positive Squamous Cell CarcinomaOropharyngeal Squamous Cell CarcinomaOropharyngeal Squamous Cell Carcinoma (SCC)

Part of Cancer, Ear, nose & throat, Infections, Mouth & dental clinical trials.

This trial tests whether giving lower doses of radiation to certain parts of the throat can be just as effective as standard doses, while reducing side effects. It is for people with HPV-positive throat cancer, which tends to respond well to treatment.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
132 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have throat cancer that tests positive for HPV (p16-positive).
  • Your cancer has not spread to other parts of the body.
  • You are 18 years or older.
  • You are in good enough health to undergo radiation therapy.
  • You have not had radiation to the head or neck area before.
  • You are able to attend follow-up visits and use effective birth control during treatment if needed.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07497607Recruiting· Phase 2
Lower radiation dose for HPV-positive throat cancer

This trial tests a lower dose of radiation to certain neck areas for people with HPV-related oropharyngeal cancer. The goal is to see if reducing radiation can cause fewer side effects while still curing the cancer.

Cincinnati, Ohio
NCT06323460Recruiting· Phase 2
Less Radiation for HPV Throat Cancer Guided by a Blood Test

This study tests a way to use less radiation for HPV-related throat cancer. Doctors will adjust your treatment based on a simple blood test that tracks cancer DNA, so you may get only the treatment you need.

Columbus, Ohio
NCT06759155Not yet recruiting· Phase 2
Less intense therapy for HPV-positive throat cancer

This trial tests a less intense treatment plan for HPV-positive throat cancer that is caught early or moderately advanced. The goal is to keep the cancer from coming back while reducing side effects from standard therapy.

NCT05600842Recruiting
Lower-dose radiation for HPV-positive throat cancer

This trial tests whether using a de-escalated (lower/intensity-reduced) radiation approach can treat HPV-positive oropharyngeal squamous cell carcinoma. It may help reduce side effects while still keeping the cancer under control.

Orange, California
NCT06984861Recruiting· Phase 2
Reduced radiation with chemo for HPV-related throat cancer

This trial tests if giving less radiation along with chemotherapy is safe and effective for people with HPV-positive throat cancer. It aims to reduce side effects while still controlling the cancer.

Basking Ridge, New Jersey
NCT05268614Recruiting· Phase 2
Risk-based reduced chemo and radiation for HPV throat cancer

This trial tests whether using a lower intensity (reduced) chemo-radiation plan can work for some people with HPV-related oropharyngeal (throat) cancer without losing effectiveness. It may help reduce side effects while still controlling the cancer.

Gainesville, Florida

Hear when a new Head and Neck Cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.